SCHEMBL22526115

SCHEMBL22526115

CC(C)C#CCCCCC(N)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN7 P35236 5/20 0.38
▸ HMGCR P04035 4/20 0.38
▸ KMT2A Q03164 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ SOAT1 P35610 2/20 0.34
▸ FAAH O00519 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ TARDBP Q13148 1/20 0.34
▸ KDM4E B2RXH2 3/20 0.32
▸ RECQL P46063 2/20 0.32
▸ TDP1 Q9NUW8 2/20 0.32
▸ USP2 O75604 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ ALOX12 P18054 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3817935 0.83 PTPN7 (0.57) PTPN7HMGCRKMT2AMEN1CYP1A2
SCHEMBL23945587 0.82 PTPN7 (0.37) PTPN7HMGCRKMT2AMEN1KDM4E
SCHEMBL22526118 0.82 PAOX (0.43) PTPN7HMGCRRECQLTDP1ALDH1A1
SCHEMBL25110937 0.82 PAOX (0.43) PTPN7HMGCRRECQLTDP1ALDH1A1
SCHEMBL7626673 0.81 PTPN7 (0.38) PTPN7HMGCRKMT2AMEN1SOAT1
SCHEMBL25468189 0.80 PTPN7 (0.40) PTPN7HMGCR
SCHEMBL24765696 0.80 PTPN7 (0.40) PTPN7HMGCR
SCHEMBL25110145 0.80 PTPN7 (0.40) PTPN7HMGCR
SCHEMBL25122683 0.79 PTPN7 (0.35) PTPN7HMGCRKMT2AMEN1KDM4E
Bicarbonate SCHEMBL4957571 0.75 PTPN7 (0.52) PTPN7HMGCRKMT2AMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020206424-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-10-08 — — WO disclosed
Send feedback